4.7 Article

Functional high-throughput screen identifies microRNAs that promote butyrate-induced death in colorectal cancer cells

期刊

MOLECULAR THERAPY-NUCLEIC ACIDS
卷 30, 期 -, 页码 30-47

出版社

CELL PRESS
DOI: 10.1016/j.omtn.2022.08.037

关键词

-

资金

  1. Flinders Foundation
  2. Tour de Cure, Australia
  3. Cancer Council's Beat Cancer
  4. South Australian State Government through the Department of Health
  5. Australian Cancer Research Foundation (ACRF)
  6. Phenomics Australia (PA)
  7. Australian Governments National Collaborative Research Infrastructure Strategy (NCRIS) program
  8. Peter MacCallum Cancer Centre Foundation
  9. University of Melbourne Research Collaborative Infrastructure Program (MCRIP)

向作者/读者索取更多资源

Butyrate, a gut fermentation product, shows anti-cancer properties in the human proximal colon by inhibiting proliferation and inducing apoptosis in colorectal cancer cells. A study identified several miRNAs such as miR-125b, miR-181a, miR-593, and miR-1227 that can enhance the anti-cancer effects of butyrate, potentially affecting critical cancer-related growth pathways.
The gut fermentation product butyrate displays anti-cancer properties in the human proximal colon, including the ability to inhibit proliferation and induce apoptosis in colorectal cancer (CRC) cells. A natural histone deacetylase inhibitor (HDACi), butyrate can alter histone acetylation patterns in CRC cells, and thereby regulate global gene expression, including the non-coding transcriptome and microRNAs (miRNAs). Dysregulated miRNA expression affects CRC development and progression; however, the interplay between miRNA activity and butyrate response remains to be elucidated. A high-throughput functional screen was employed to identify miRNAs that can act as enhancers of the anti-cancer properties of butyrate. Validation studies confirmed that several miRNAs, including miR-125b, miR-181a, miR-593, and miR-1227, enhanced apoptosis, decreased proliferation, and promoted cell-cycle arrest in the presence of butyrate. Pathway analyses of predicted miRNA target genes highlighted their likely involvement in critical cancer-related growth pathways, including WNT and PI3K signaling. Several cancer-associated miRNA targets, including TRIM29, COX2, PIK3R3, CCND1, MET, EEF2K, DVL3, and NUP62 were synergistically regulated by the combination of cognate miRNAs and butyrate. Overall, this study has exposed the potential of miRNAs to act as enhancers of the anti-cancer effects of HDAC inhibition and identifies specific miRNAs that might be exploited for therapeutic benefit.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据